Work

Phase II clinical study of the efficacy and safety of adebrelimab in combination with lenvatinib as second-line treatment for advanced intrahepatic cholangiocarcinoma: Updated results.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e16162

Authors: Xiujuan Chang, Hu Li, Meng Zhang, Di Wang, Jianzhi Pang, Jiagan Huang, Wei Zhang, Huaifang Kong, Huixin Zhang, Xudong Gao, Yinjie Gao, Jiaqi Chen, Jiali Zhao, Aji Wang, Yan Chen, Man Gong, Yan Liu, Zhenyu Zhu, Zhen Zeng

Institutions: Chinese PLA General Hospital, Peking University

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, National Health Commission of the People's Republic of China

OpenAlex ID: W7162685306

Cites:

Cited by:

Related to: